Recent studies have demonstrated that HDAC inhibitors, such as romidepsin, can effectively downregulate neuropilin-1 (NRP1) in osteosarcoma cells, thereby significantly reducing their metastatic potential [32]. The gene discussed is HDAC9; the disease is osteosarcoma.